A controlled study of the antihypertensive effect of carteolol, a new?-adrenergic receptor blocking drug, in combination with hydrochlorthiazide and amiloride

This publication has 10 references indexed in Scilit:

• Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
  1977
• The effect on blood pressure of beta‐adrenoceptor blocking drugs administered once daily and their duration of action when therapy is ceased.
  British Journal of Clinical Pharmacology, 1976
• COMPARISON OF NEWLY SYNTHESIZED β-ADRENERGIC BLOCKERS, OPC 1085 AND SQ 11725, WITH PINDOLOL AND PROPRANOLOL IN THE BLOOD-PERFUSED CANINE SA NODE AND PAPILLARY MUSCLE PREPARATIONS
  The Japanese Journal of Pharmacology, 1976
• Metabolic fate of carteolol hydrochloride (OPC-1085), a new β-adrenergic blocking agent. III. Autoradiographic distribution studies in mice.
  Folia Pharmacologica Japonica, 1976
• Return of elevated blood pressure after withdrawal of antihypertensive drugs.
  Circulation, 1975
• Effects of 5-(3-tert-butylamino-2-hydroxy) propoxy-3, 4-dihydrocarbostyril hydrochloride (OPC-1085), a new beta-adrenergic blocking agent on the coronary circulation and myocardial metabolism
  Folia Pharmacologica Japonica, 1975
• Derivatives of 3,4-dihydrocarbostyril as .beta.-adrenergic blocking agents
  Journal of Medicinal Chemistry, 1974
• Pharmacokinetics of pindolol in man
  European Journal of Clinical Pharmacology, 1974
• CARDIOVASCULAR STUDIES OF 5-(3-TERT-BUTYLAMINO-2-HYDROXY) PROPOXY-3,4-DIHYDROCARBOSTYRIL HYDROCHLORIDE (OPC- IOS5), A NEW POTENT β-ADRENERGIC BLOCKING AGENT
  The Japanese Journal of Pharmacology, 1974
• Perspectives in adrenergic beta‐receptor blockade
  Clinical Pharmacology & Therapeutics, 1969